| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | G-One Ahn | Q89392327 |
| P2093 | author name string | J Martin Brown | |
| P2860 | cites work | VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells | Q82264553 |
| VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche | Q24600542 | ||
| Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization | Q24646424 | ||
| Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization | Q24673319 | ||
| Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
| Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth | Q28203327 | ||
| Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration | Q28207902 | ||
| Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis | Q28264314 | ||
| Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis | Q28275735 | ||
| Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth | Q28278074 | ||
| Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas | Q28291374 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice | Q28385532 | ||
| Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
| Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
| Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents | Q30438696 | ||
| Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells | Q33186709 | ||
| Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas | Q33382708 | ||
| MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis | Q33744153 | ||
| p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow. | Q33771424 | ||
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. | Q34136366 | ||
| Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells | Q34257800 | ||
| Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis | Q34320916 | ||
| Macrophages regulate the angiogenic switch in a mouse model of breast cancer | Q34582812 | ||
| Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma | Q34768337 | ||
| TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis | Q34785288 | ||
| Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis | Q34928194 | ||
| Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? | Q34988256 | ||
| Myeloid lineage progenitors give rise to vascular endothelium. | Q35016546 | ||
| Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis | Q35198652 | ||
| Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization | Q36227849 | ||
| Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis | Q36464443 | ||
| Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature | Q36591314 | ||
| Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer | Q36613812 | ||
| Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages | Q36742291 | ||
| VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma | Q36858190 | ||
| Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells | Q37039337 | ||
| HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion | Q37098976 | ||
| Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site | Q37118459 | ||
| Mesenchymal stem cells: the fibroblasts' new clothes? | Q37358415 | ||
| An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. | Q37486791 | ||
| Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells | Q39976240 | ||
| Bv8 regulates myeloid-cell-dependent tumour angiogenesis | Q40038500 | ||
| Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. | Q40100311 | ||
| A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism | Q40112546 | ||
| Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer | Q40149456 | ||
| Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. | Q40228810 | ||
| VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization | Q40271297 | ||
| Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer | Q40500955 | ||
| Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. | Q40609424 | ||
| Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. | Q40610526 | ||
| Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells | Q42451021 | ||
| Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. | Q44928916 | ||
| Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells | Q45862226 | ||
| Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors | Q46273904 | ||
| 17Beta-estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors | Q46448076 | ||
| Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells. | Q46636424 | ||
| Blood monocytes mimic endothelial progenitor cells | Q46686010 | ||
| Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. | Q46755323 | ||
| Adaptive immunity maintains occult cancer in an equilibrium state | Q46891052 | ||
| Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes | Q48418477 | ||
| Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. | Q50754378 | ||
| Universal GFP reporter for the study of vascular development. | Q52163301 | ||
| Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. | Q53473696 | ||
| Contribution of bone marrow–derived endothelial cells to human tumor vasculature | Q57413787 | ||
| Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis | Q59276609 | ||
| Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients | Q61787495 | ||
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 | ||
| Vascular endothelial cell lineage-specific promoter in transgenic mice | Q72221061 | ||
| Tumor response to radiotherapy regulated by endothelial cell apoptosis | Q73401346 | ||
| Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation | Q74823576 | ||
| Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 | ||
| Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study | Q77586996 | ||
| P433 | issue | 2 | |
| P921 | main subject | endothelium | Q111140 |
| bone marrow | Q546523 | ||
| P304 | page(s) | 159-164 | |
| P577 | publication date | 2009-02-17 | |
| P1433 | published in | Angiogenesis | Q15753544 |
| P1476 | title | Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature | |
| P478 | volume | 12 |
| Q46688397 | Acidic stress induces apoptosis and inhibits angiogenesis in human bone marrow-derived endothelial progenitor cells |
| Q39696428 | Angiogenesis and multiple myeloma |
| Q43143507 | Angiogenic monocytes: another colorful blow to endothelial progenitors |
| Q36390700 | Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks |
| Q53287381 | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. |
| Q37998010 | CX3CL1/fractalkine is a novel regulator of normal and malignant human B cell function |
| Q42703790 | Cerebral microvascular rarefaction induced by whole brain radiation is reversible by systemic hypoxia in mice |
| Q38800593 | Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments |
| Q34762886 | Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma |
| Q37148144 | Combined hyperthermia and radiotherapy for the treatment of cancer |
| Q37594031 | Different but synergistic effects of bone marrow-derived VEGFR2+ and VEGFR2-CD45+ cells during hepatocellular carcinoma progression |
| Q49544357 | Disrupting Tumor Angiogenesis and "the Hunger Games" for Breast Cancer |
| Q83961045 | Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1 |
| Q34849698 | Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. |
| Q35441276 | Endothelial TWIST1 promotes pathological ocular angiogenesis. |
| Q34756376 | Endothelial progenitor cells contribute to the vascularization of endometriotic lesions |
| Q38065976 | Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies |
| Q37388217 | High-grade glioma in elderly patients: can the oncogeriatrician help? |
| Q27301577 | High-resolution in-vivo analysis of normal brain response to cranial irradiation |
| Q37209090 | Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation |
| Q36476333 | Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis |
| Q24297946 | Inhibition of β1 integrin and IL-3Rβ common subunit interaction hinders tumour angiogenesis |
| Q33753956 | Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a |
| Q38304820 | Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities |
| Q36983319 | Macrophages and chemokines as mediators of angiogenesis |
| Q34972161 | Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates |
| Q33977030 | Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme |
| Q37707680 | Method for in vitro differentiation of bone marrow mesenchymal stem cells into endothelial progenitor cells and vascular endothelial cells |
| Q33994431 | MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1 |
| Q38613648 | Myeloid Derived Suppressor Cells: Fuel the Fire |
| Q37721657 | NF-kappaB fans the flames of lung carcinogenesis |
| Q35945915 | Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy. |
| Q37118895 | Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era |
| Q35789092 | PTK7+ Mononuclear Cells Express VEGFR2 and Contribute to Vascular Stabilization by Upregulating Angiopoietin-1. |
| Q34765380 | Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas |
| Q37998372 | Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives |
| Q38294597 | Radiobiological modifiers in clinical radiation oncology: current reality and future potential |
| Q26824117 | Recent advances in bone regeneration using adult stem cells |
| Q26766306 | Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis |
| Q36828773 | Spheroid-plug model as a tool to study tumor development, angiogenesis, and heterogeneity in vivo. |
| Q37806811 | Stem cells in tumor angiogenesis |
| Q37531724 | Strategies for optimizing the response of cancer and normal tissues to radiation |
| Q37856721 | Strategies to improve radiotherapy with targeted drugs |
| Q41626389 | Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation |
| Q34201082 | Systemic influences contribute to prolonged microvascular rarefaction after brain irradiation: a role for endothelial progenitor cells |
| Q26824766 | Targeting angiogenesis in gynecologic cancers |
| Q36526512 | The VEGF pathway in cancer and disease: responses, resistance, and the path forward. |
| Q46444221 | The kinetics and apoptotic profile of circulating endothelial cells in autologous hematopoietic stem cell transplantation in patients with lymphoproliferative disorders |
| Q35216064 | The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells |
| Q42141349 | Transplantation of vascular endothelial growth factor 165‑transfected endothelial progenitor cells for the treatment of limb ischemia |
| Q39001566 | Tumor vasculature is regulated by FGF/FGFR signaling-mediated angiogenesis and bone marrow-derived cell recruitment: this mechanism is inhibited by SSR128129E, the first allosteric antagonist of FGFRs |
| Q37281066 | Tumour cells coerce host tissue to cancer spread |
| Q38126351 | Vascular remodeling in cancer. |
| Q38150963 | Whole brain radiation-induced vascular cognitive impairment: mechanisms and implications |
Search more.